Intravenous morphine and chest pain

Clinical Cardiology

Volumn 34, Issue 8, 2011, Pages 464-465

  Conti, C Richard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; LOOP DIURETIC AGENT; MORPHINE SULFATE; NITRATE; NITROPRUSSIDE SODIUM;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; ANXIETY; BLOOD PRESSURE; CARDIAC PATIENT; DRUG DOSE INCREASE; HEART MUSCLE ISCHEMIA; HUMAN; HYPOTENSION; LUNG EDEMA; MEDICAL PRACTICE; NAUSEA; NOTE; OXYGEN CONSUMPTION; PRACTICE GUIDELINE; RESPIRATION DEPRESSION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; HUMANS; MORPHINE; MYOCARDIAL INFARCTION; MYOCARDIUM; NARCOTICS; OXYGEN CONSUMPTION; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT;

EID: 80051504961     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20927     Document Type: Note

References (2)

1. Herrick JB., Clinical features of sudden obstruction of the coronary arteries. JAMA. 1912; 59: 2015-2022.
2. Meine TG, Roe MT, Chen AY, et al. for the CRUSADE Investigators, Durham and Chapel Hill NC, Cleveland and Cincinnati Ohio, and Philadelphia PA. Association of Intravenous Morphine Use and Outcomes in Acute Coronary Syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J. 2005; 149: 1043-1049. (Pubitemid 40848149)